Late vitamin K deficiency bleeding in infants: five-year prospective study

Salah Hashim Al-Zuhairy1

  • 1Department of Pediatrics, College of Medicine, University of Misan, Amarah, Iraq.

Jornal De Pediatria
|October 16, 2020
PubMed

Insights

Late vitamin K deficiency bleeding (VKDB) is a serious condition in infants, especially when prophylaxis isn't routine. Secondary VKDB is more common, with significant bleeding risks and lethality.

Area of Science:

  • Pediatrics
  • Neonatology
  • Hematology

Background:

  • Late vitamin K deficiency bleeding (VKDB) poses a significant health risk to infants.
  • Understanding the clinical features, risk factors, and outcomes of VKDB is crucial for timely diagnosis and management.

Purpose of the Study:

  • To investigate the clinical and demographic characteristics of infants diagnosed with late-onset VKDB.
  • To identify risk factors associated with primary and secondary VKDB subtypes.
  • To evaluate the outcomes and lethality rates in affected infants.

Main Methods:

  • A 5-year observational study evaluated 47 infants under 6 months with late VKDB.
  • Diagnosis was based on clinical history, physical examination, and laboratory findings.
  • Infants were classified into primary (breastfeeding-related) and secondary (additional risk factors) VKDB subtypes.

Main Results:

  • Secondary late VKDB was more prevalent (83%) than the primary subtype.
  • Common bleeding sites included the gastrointestinal tract (40.4%) and intracranial hemorrhage (32%).
  • Neurological complications occurred in 21% of patients, with an overall lethality rate of 23%.

Conclusions:

  • Late VKDB remains a serious concern in regions with no routine vitamin K prophylaxis at birth.
  • Secondary late VKDB is more common, highlighting the need to identify and address additional risk factors.
  • The study underscores the critical nature of VKDB, emphasizing the importance of preventive measures.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.7K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
133
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
138
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
176